HAP Trading’s Ascendis Pharma A/S ASND Stock Holding History

HAP Trading’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-40,000	Closed	-$134K	–	723
2023 Q4	$134K	Buy	+40,000	New	+$3.99M	0.02%	333
2023 Q1	–	Sell	-65,000	Closed	-$192K	–	1178
2022 Q4	$192K	Sell	65,000 -35,000	-35%	-$4.06M	0.02%	481
2022 Q3	$165K	Buy	+100,000	New	+$9.48M	0.01%	662
2022 Q2	–	Sell	-10,100	Closed	-$18K	–	1933
2022 Q1	$18K	Buy	+10,100	New	+$1.17M	﹤0.01%	1611
2020 Q4	–	Sell	-30,000	Closed	-$885K	–	2192
2020 Q3	$885K	Hold	30,000	–	–	0.04%	289
2020 Q2	$882K	Buy	+30,000	New	+$4.12M	0.05%	297

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HAP Trading's ASND Position: Q1 2024 in Review

HAP Trading sold out of Ascendis Pharma A/S (ASND) in Q1 2024, closing a stake of 12,299 shares — an estimated $1.55M sold.

HAP Trading first reported a position in ASND in Q3 2022 and held it in 2 quarters. The position peaked at $1.88M in Q3 2022. 189 funds tracked by Wall St. Rank hold ASND as of Q1 2024.

HAP Trading reported no remaining Ascendis Pharma A/S position as of Q1 2024 after selling out during the quarter.
HAP Trading sold 12,299 Ascendis Pharma A/S shares in Q1 2024, an estimated $1.55M.
HAP Trading first reported a position in Ascendis Pharma A/S in Q3 2022 and held it in 2 quarters.
HAP Trading's Ascendis Pharma A/S position peaked at $1.88M in Q3 2022.
189 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2024.

Based on HAP Trading's 13F filing for Q1 2024, filed 13 May 2024.